Cargando…
Era of biosimilars in rheumatology: reshaping the healthcare environment
Compared with the original approved biological drug on which it is based, a biosimilar has highly similar physicochemical characteristics and biological activity, as well as equivalent efficacy and no clinically meaningful differences in safety and immunogenicity. Before they are approved, biosimila...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560670/ https://www.ncbi.nlm.nih.gov/pubmed/31245050 http://dx.doi.org/10.1136/rmdopen-2019-000900 |